Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Vojtech Petr

TitlePost-Doctoral Fellow
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Zahradka I, Petr V, Modos I, Jakubov K, Dolezal L, Kalina S, Viklicky O. Prediction and phenotyping of long COVID in kidney transplant recipients: A cross-sectional study. Clin Nephrol. 2025 Jun; 103(6):366-376. PMID: 40130884.
      View in: PubMed
    2. Viklicky O, Zahradka I, Mares J, Slatinska J, Parikova A, Petr V, Roder M, Jaklova K, Osickova K, Janousek L, Hruba P. 12-Month Outcomes of a Prospective Randomized Trial Investigating Effects of IVIG on Top of rATG Versus rATG Alone in Pre-Sensitized Kidney Transplant Recipients: The INHIBIT Study. Transpl Int. 2025; 38:14312. PMID: 40458542.
      View in: PubMed
    3. Zahradka I, Petr V, Paces J, Zdychova J, Srbova A, Limberkova R, Suri T, Tichanek F, Husakova D, Jirincova H, Hradilova M, Striz I, Viklicky O. Low risk of prolonged SARS-CoV-2 shedding and molecular evolution in kidney transplant recipients during the Omicron era: A prospective observational study. Am J Transplant. 2025 May; 25(5):1002-1012. PMID: 39638044.
      View in: PubMed
    4. Jakubov K, Petr V, Zahradka I, Girmanova E, Hruba P, Keleman R, Viklicky O. Acute Kidney Injury in Deceased Organ Donors: Risk Factors And Impacts on Transplantation Outcomes. Transplant Direct. 2024 Dec; 10(12):e1730. PMID: 39553743.
      View in: PubMed
    5. Fialova M, Cecrdlova E, Zahradka I, Petr V, Hruby F, Modos I, Viklicky O, Striz I. Attenuated neutralization, maintained specificity: Humoral response to SARS-CoV-2 booster in kidney allograft recipients. Diagn Microbiol Infect Dis. 2025 Jan; 111(1):116550. PMID: 39437653.
      View in: PubMed
    6. Petr V, Zahradka I, Modos I, Roder M, Fialova M, Machkova J, Kabrtova K, Hruba P, Magicova M, Slavcev A, Striz I, Viklicky O. Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine Booster Doses in Kidney Transplant Recipients: Results of a 12-mo Follow-up From a Prospective Observational Study. Transplant Direct. 2024 Jun; 10(6):e1645. PMID: 38769974.
      View in: PubMed
    7. Petr V, Zahradka I, Viklicky O. Calcineurin inhibitor toxicity in de novo thrombotic microangiopathy-Is the culprit what we think it is? Am J Transplant. 2024 Sep; 24(9):1708-1709. PMID: 38677652.
      View in: PubMed
    8. Zahradka I, Tichanek F, Magicova M, Modos I, Viklicky O, Petr V. Morning administration enhances humoral response to SARS-CoV-2 vaccination in kidney transplant recipients. Am J Transplant. 2024 Sep; 24(9):1690-1697. PMID: 38460787.
      View in: PubMed
    9. Petr V, Thurman JM. The role of complement in kidney disease. Nat Rev Nephrol. 2023 12; 19(12):771-787. PMID: 37735215.
      View in: PubMed
    10. Zahradka I, Petr V, Jakubov K, Modos I, Hruby F, Viklicky O. Early referring saved lives in kidney transplant recipients with COVID-19: a beneficial role of telemedicine. Front Med (Lausanne). 2023; 10:1252822. PMID: 37795416.
      View in: PubMed
    11. Eskandari SK, Gaya da Costa M, Faria B, Petr V, Azzi JR, Berger SP, Seelen MAJ, Damman J, Poppelaars F. An interleukin 6-based genetic risk score strengthened with interleukin 10 polymorphisms associated with long-term kidney allograft outcomes. Am J Transplant. 2022 12; 22 Suppl 4:45-57. PMID: 36453708.
      View in: PubMed
    12. Petr V, Zahradka I, Modos I, Roder M, Prewett A, Fialova M, Machkova J, Hruba P, Magicova M, Slavcev A, Striz I, Viklicky O. First Booster of SARS-COV-2 mRNA Vaccine Is Not Associated With Alloimmunization and Subclinical Injury of Kidney Allograft. Transplantation. 2023 02 01; 107(2):e62-e64. PMID: 36314999.
      View in: PubMed
    13. Zahradka I, Petr V, Modos I, Kabrtova K, Slavcev A, Viklicky O. SARS-CoV-2 mRNA Vaccination Is Not Associated With the Risk of Allosensitization in Patients Awaiting Kidney Transplantation. Transplantation. 2022 12 01; 106(12):e522-e524. PMID: 36245078.
      View in: PubMed
    14. Petr V, Csuka D, Hruba P, Szil?gyi ?, Kollar M, Slavcev A, Proh?szka Z, Viklicky O. MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy. Front Immunol. 2022; 13:985766. PMID: 36189289.
      View in: PubMed
    15. Zahradka I, Petr V, Modos I, Magicova M, Dusek L, Viklicky O. Association Between SARS-CoV-2 Messenger RNA Vaccines and Lower Infection Rates in Kidney Transplant Recipients : A Registry-Based Report. Ann Intern Med. 2022 07; 175(7):961-968. PMID: 35500256.
      View in: PubMed
    16. Zahradka I, Petr V, Magicova M, Viklicky O. Background risk should be taken into account when reporting vaccine effectiveness. Am J Transplant. 2022 07; 22(7):1927-1928. PMID: 35043536.
      View in: PubMed
    17. Kainz A, Kammer M, Reindl-Schwaighofer R, Strohmaier S, Petr V, Viklicky O, Abramowicz D, Naik M, Mayer G, Oberbauer R. Waiting Time for Second Kidney Transplantation and Mortality. Clin J Am Soc Nephrol. 2022 01; 17(1):90-97. PMID: 34965955.
      View in: PubMed
    18. Petr V, Hruba P, Kollar M, Krejci K, Safranek R, Stepankova S, Dedochova J, Machova J, Zieg J, Slatinska J, Pokorna E, Viklicky O. Rejection-associated Phenotype of De Novo Thrombotic Microangiopathy Represents a Risk for Premature Graft Loss. Transplant Direct. 2021 Nov; 7(11):e779. PMID: 34712779.
      View in: PubMed
    19. Cahova M, Kveton M, Petr V, Funda D, Dankova H, Viklicky O, Hruba P. Local Angiotensin-Converting Enzyme 2 Gene Expression in Kidney Allografts Is Not Affected by Renin-Angiotensin-Aldosterone Inhibitors. Kidney Blood Press Res. 2021; 46(2):245-249. PMID: 33756485.
      View in: PubMed
    Petr's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (62) concept(s)
    _
    Co-Authors Expand Description
    See all (2) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)